Clesrovimab (MK-1654) in Infants and Children at Increased Risk for Severe Respiratory Syncytial Virus (RSV) Disease (MK-1654-007)
Clinical trial NCT04938830 · COMPLETED
Trial details
- NCT number
- NCT04938830
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-11-30
- Primary completion
- 2025-04-28
- Enrollment
- 1003
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.